BCRX

| Held by: VTI XBI IWM VB VXF IWO IBB VBK CALF VTWO

Index	RUT	P/E	-	EPS (ttm)	-1.78	Insider Own	9.72%	Shs Outstand	254.01M	Perf Week	4.55%
Market Cap	2.28B	Forward P/E	28.63	EPS next Y	0.31	Insider Trans	-1.86%	Shs Float	229.77M	Perf Month	-5.58%
Enterprise Value	2.90B	PEG	-	EPS next Q	0.16	Inst Own	83.13%	Short Float	16.28%	Perf Quarter	29.06%
Income	-457.98M	P/S	2.57	EPS this Y	-321.28%	Inst Trans	5.81%	Short Ratio	6.80	Perf Half Y	30.00%
Sales	885.72M	P/B	-	EPS next Y	111.70%	ROA	-96.92%	Short Interest	37.42M	Perf YTD	15.00%
Book/sh	-2.18	P/C	9.53	EPS next 5Y	-29.26%	ROE	-	52W High	11.31 -20.69%	Perf Year	-12.40%
Cash/sh	0.94	P/FCF	7.78	EPS past 3/5Y	- -	ROIC	-175.59%	52W Low	6.00 49.50%	Perf 3Y	7.17%
Dividend Est.	-	EV/EBITDA	9.11	Sales past 3/5Y	47.82% 117.89%	Gross Margin	97.52%	Volatility	5.92% 5.22%	Perf 5Y	-37.62%
Dividend TTM	-	EV/Sales	3.27	EPS Y/Y TTM	-569.22%	Oper. Margin	35.67%	ATR (14)	0.46	Perf 10Y	191.23%
Dividend Ex-Date	-	Quick Ratio	1.88	Sales Y/Y TTM	75.92%	Profit Margin	-51.71%	RSI (14)	48.34	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.91	EPS Q/Q	-2979600.00%	SMA20	-0.06%	Beta	0.58	Target Price	21.30
Payout	0.00%	Debt/Eq	-	Sales Q/Q	7.48%	SMA50	-2.35%	Rel Volume	0.67	Prev Close	9.02
Employees	435	LT Debt/Eq	-	Earnings	May 06 BMO	SMA200	13.41%	Avg Volume	5.50M	Price	8.97
IPO	Mar 04, 1994	Option/Short	Yes / Yes	EPS/Sales Surpr.	-6826.86% 3.50%	Trades		Volume	3,665,028	Change	-0.55%

Biocryst Pharmaceuticals Inc

Upgrade your Finviz experience